FRONT-LINE THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE, OFATUMUMAB (FC-O2) IN YOUNG (<= 65 YRS) AND FIT CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. RESULTS OF THE PROSPECTIVE PHASE 2 GIMEMA STUDY LLC0911

Mauro, FR;Molica, S;Zaja, F;Piciocchi, A;Ilariucci, F;Coscia, M;Carella, AM;Re, F;Liberati, AM;Tedeschi, A;Gozzetti, A;Cuneo, A;Cortelezzi, A;Baraldi, A;Del Poeta, G;Musolino, C;Battistini, R;De Propris, MS;Della Starza, I;Raponi, S;Ilari, C;Cafforio, L;Nanni, M;Fazi, P;Vignetti, M;Russo, F;Porrazzo, M;Riemma, C;Specchia, G;Neri, A;Guarini, A;Foa, R

2017-01-01